15 Stocks With The Highest Forecast Sales Growth - Ashford (AMEX:AINC)

As the year 2017 is just few days away, many investors are in the process of adjusting their stock picks for the next year, which could potentially see a corporate tax reform, higher interest rates, the repeal of the Affordable Care Act and reduced regulation under President-elect Donald Trump's administration.

Against this backdrop, Benzinga provides a list of 15 stocks with the highest forecast sales growth. The criteria: trailing 12-month revenue of greater than $20 million. The following list will showcase small and mid-cap companies that are expected to generate several times better 2017 sales versus last year, as projected by Wall Street consensus.

Our list comprises mainly pharma and energy firms. Many pharma companies will see accelerated revenue from new products and licensing deals, while an expected rise in oil prices is a positive catalyst for the entire energy sector. In particular, several energy firms may restart potential growth projects, which have been idled during the commodity price downturn.

Following is the list of 15 names set to deliver highest sales growth in 2017.

Symbol	Name	Revenue (TTM), In Millions	Revenue Est. For Current Fiscal Year, In Millions	Revenue Est. For Next Fiscal Year, In Millions
AINC	Ashford Inc AINC	64.98	65.70	167.90
ARLZ	Aralez Pharmaceuticals Inc ARLZ	40.23	56.12	141.35
CQH	Cheniere Energy Partners LP Holdings LLC CQH	20.34	20.35	201.60
CQP	Cheniere Energy Partners LP CQP	616.90	985.35	2,746
ERII	Energy Recovery, Inc. ERII	53.05	49.72	117.65
ESTE	Earthstone Energy Inc ESTE	35.52	43.11	129.39
EVHC	Envision Healthcare Holdings Inc EVHC	3,010	3,715	10,710
GLNG	Golar LNG Limited (USA) GLNG	80.19	85.53	208.78
KITE	Kite Pharma Inc KITE	22.15	22.72	61.30
LNG	Cheniere Energy, Inc. LNG	780.01	1,311	3,726
OMED	Oncomed Pharmaceuticals Inc OMED	25.77	26.56	90.04
OREX	Orexigen Therapeutics, Inc. OREX	24.76	33.96	84.57
PHMD	PhotoMedex Inc PHMD	47.03	90.82	248.42
TSRO	TESARO Inc TSRO	40.83	47.04	131.90
TXMD	TherapeuticsMD Inc TXMD	20.50	20.77	49.14

Market News and Data brought to you by Benzinga APIs